Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2002-08-23 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13001), Bouches-du-Rhone
SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS : revenue, balance sheet and financial ratios
SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13001),
this company of category PME
shows in 2017 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS (SIREN 443265244)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 213 301 €
1 362 625 €
1 371 946 €
Net income
80 452 €
52 870 €
60 028 €
62 204 €
80 483 €
75 584 €
3 849 €
-36 772 €
-22 536 €
-109 112 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
-17 952 €
-5 057 €
9 080 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
-3.0%
-1.7%
-8.0%
Revenue and income statement
In 2024, SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS generates positive net income of 80 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
80 452 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.0%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.411%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
558.689
696.835
1368.35
1085.868
312.067
177.283
132.915
0.095
0.316
0.0
Financial autonomy
9.213
6.84
2.788
3.053
9.724
17.13
21.215
28.183
34.369
42.411
Repayment capacity
-4.437
-21.051
-9.842
None
None
None
None
None
None
None
Cash flow / Revenue
-7.87%
-1.473%
-3.029%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
0.02024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent
In 2024, the debt ratio of SELARL GRANDE PHARMACIE D... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
42.41%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+16 pts over 3 years
In 2024, the financial autonomy of SELARL GRANDE PHARMACIE D... (42.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 46.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
46.009
Liquidity indicators evolution SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
42.857
34.745
32.301
36.227
48.826
55.881
68.248
41.859
41.319
46.009
Interest coverage
218.084
-370.833
-89.996
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
46.012024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of SELARL GRANDE PHARMACIE D... (46.01) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
-4 802 €
13 081 €
-28 682 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
17
18
17
0
0
0
0
0
0
0
Customer payment term (days)
8
7
6
0
0
0
0
0
0
0
Supplier payment term (days)
65
89
143
0
0
0
0
0
0
0
Positioning of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS is estimated at
1 123 169 €
(range 782 157€ - 1 680 325€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
782k€1123k€1680k€
1 123 169 €Range: 782 157€ - 1 680 325€
NAF 5 année 2024
Valuation method used
Net Income Multiple
80 452 €
×
14.0x
=1 123 169 €
Range: 782 157€ - 1 680 326€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS with other companies in the same sector:
Frequently asked questions about SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS
What is the revenue of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS ?
The revenue of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS in 2017 is 1.2 M€.
Is SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS profitable?
Yes, SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS generated a net profit of 80 k€ in 2024.
Where is the headquarters of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS ?
The headquarters of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS is located in MARSEILLE (13001), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS ?
The tax return of SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS operate?
SELARL GRANDE PHARMACIE DU MARCHE DES CAPUCINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart